Medical Research Ethics in Developing
Cairo UniversityEthics
Medical Research Ethics Committees (MRECs)
Information about MRECs activities in
developing countries is limited. Research ethics committees (RECs) in these
countries were reported to have limited expertise while ethics principles are
still in their early stages. Members of these committees meet infrequently, have
no formal training in ethics and many lack important financial and
administration resources. Against this, there is an exponential increase in
clinical drug trials funded with multi-national pharmaceutical companies.
Countries of the developing world offer many advantages, mainly lower overhead
costs for conducting drug trials when compared to industrial nations.
Supervision and monitoring mechanisms are either weak, absent or amenable to manipulation.
Offering unproven therapy and exploiting desperate patients are other problems.
Egypt
with a population of 85
millions, very low per capita income and very limited annual health care
expenditure has witnessed a recent intensity of research activities, and
similar to other developing countries, there is a growing concern with the
potential for exploitation in the area of international research. Therefore,
the establishment of MRE committees is critical in order to ensure that risks
to subjects are minimized and reasonable in relation to anticipated benefits.
Respect for the dignity of research subjects, to make appropriate compensation
MRECs in Egypt
The present regulations in Egypt
are governed by the Egypt Constitution (1971, part 3, article 43: "Any
medical or scientific experiment may not be undergone on any persons without
his free consent". Also by the Profession Ethics Regulations issued by the
Minister of Health and Population No. 238/2003, article 52-61. In
Egypt
, the
total number of RECs is 15, most being affiliated to universities with medical
schools and research institutions. In addition, a recently developed REC has
been started in the Ministry of Health and a single private independent REC
Cairo University Medical Research Ethics Committee
Established in 2003 after approval of
the medical school dean and board of directors. The new committee members and
chairman were selected and approved by the board of directors in 2008. In 2011 a
new set of regulations was approved by the committee members which addressed the
required documents to be reported to the committee, details of the consent
form, rules governing research protocols evaluation, committee decisions and
recommendations. Research protocols reviewing procedures follow international
guidelines (Declaration of Helsinki, International Ethical Guidelines for
Biomedical Research Involving Human Subjects and the Council of International
Organization of Medical Societies-(CIOMS). Committee members meet regularly at
monthly intervals.
During
the period 2008 to June 2011, a total of 150 protocols were reviewed by
committee members, 39% of protocols were multi-center projects and 7% national
collaboration projects.
Decisions Regarding Submitted Protocols: 67% approval, 27% conditional approval, 16%
deferral and 1% disapproval.
Types of Research: Experimental studies phase III constitute the
majority of research protocols (32%), 19% were observational descriptive
studies, 17% experimental studies phase II, 14% observational analytic studies,
6% experimental studies phase IV, 6% diagnostic test evaluation studies, other
categories in 12%. 53% of studies were randomized trials and 34% have placebo
groups, 11% involved genetic testing and 6% stem cell research.
Consent: A
written consent was available in 80% of studies.
Sources of Funding: 44% were self-funded by the investigators, 40%
were funded by international pharmaceutical companies, 10% by international
agencies, 3% by Egyptian government and 3% local national, pharmaceutical
companies.
Other Activities of the REC: Organization of annual workshop, establishment of
REC filing system and database, generation of a number of documents covering
standard operating procedures, standardized application form, standardized
review form, confidentiality agreement form, and REC annual report.
Future Activities: Establishment of REC complete management
information systems, release of research protocol online system and a research
ethics training modules for researchers- "Video Conference Unit."
-
-
M.
Mohsen Ibrahim, MD
Prof.
of Cardiology- Cairo University
President of the Egyptian Hypertension Society